Spinal Non-Fusion Devices Market Insights, Competitive Landscape and Market Forecast-2030

Spinal Non-Fusion Devices Market By Product Type (Artificial Disc [Lumbar And Cervical], Dynamic Stabilization Devices, Facet Replacement Systems, Others), Application (Spinal Stenosis, Degenerative Disc Disease, Spondylolisthesis, And Others), End-User (Hospitals, Speciality Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to rise in the prevalence of spinal disorders and technological advancements in product portfolio, among others
The Spinal Non-Fusion Devices market was valued at USD 2,757.17 million in 2023 and is likely to register a CAGR of 5.22% during the forecast period from 2024 to 2030 to reach USD 3,731.02 million by 2030. The demand for spinal non-fusion devices is primarily being boosted owing to key factors such as the increasing prevalence of spinal disorders and deformities like spinal stenosis, degenerative disc disease (DDD), and others coupled with the rising burden of the geriatric population, and technological advancements in product portfolio coupled with increasing product development activities during the forecast period.

Spinal Non-Fusion Devices Market Dynamics:

One of the major factors influencing the growth of the spinal non-fusion devices market is the rising prevalence of spine-related disorders. The increasing number of individuals with spine-related disorders including spinal stenosis, lower back pain (LBP), and others is expected to drive the spinal non-fusion devices market in the upcoming years.

According to World Health Organization (WHO) 2023, globally about 619 million people were affected from low back pain (LBP) in 2020. The above-mentioned source estimated that by 2050, there will be around 843 million cases of lower back pain (LBP) owing to increased burden of population expansion and ageing.

In addition, the rise in road traffic accidents is further going to accelerate the demand for the spinal non-fusion devices market. Light and fatal injuries owing to sudden road accidents lead to disability sometimes and increase the need for spinal non-fusion devices such as artificial discs, and others, positively impacting the growth of the spinal non-fusion devices market. For instance, according to WHO 2022, approximately 20-50 million individuals suffer from non-fatal injuries or some sort of disability due to road traffic accidents every year on average.

Another key factor responsible for the growth of the spinal non-fusion devices market is the increasing technological developments in the product portfolio. Artificial discs, an effective and efficient alternative for spinal fusion procedures intended for the removal of the problematic discs have undergone tremendous innovation and technological developments over the years.

The robust designs of artificial discs, more choices on the market, expansion of indications, and better design discs that can be used for those expanded indications are fewer advancements that have increased their popularity among the various end-users and patients. Hence, due to the growing number of people associated with spinal disorders, accidents, and the increasing technical innovations in spinal non-fusion devices, the demand for them is likely to increase which is expected to propel the growth of the overall spinal non-fusion devices market during the forecast period from 2024-2030.

However, the availability of alternative products, and the stringent product approval process, among others may restrict the growth of the overall spinal non-fusion devices market.

Spinal Non-Fusion Devices Market Segment Analysis:

Spinal Non-Fusion Devices Market by Product Type (Artificial Disc [Lumbar and Cervical], Dynamic Stabilization Devices, Facet Replacement Systems, Others), Application (Spinal Stenosis, Degenerative Disc Disease, Spondylolisthesis, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the overall Spinal Non-Fusion devices market, the artificial discs category is expected to hold the largest share of 58.99% in the year 2023. This can be attributed to the wide applications and advantages associated with the lumbar and cervical artificial discs of the spinal non-fusion devices market during the given forecast period.

The goal of artificial disc replacement is to alleviate pain by reducing aggravating micromotion, stabilizing the spinal segment, and minimizing inflammation. Further, one advantage of the artificial lumbar disc is that it may also prevent premature breakdown of adjacent levels of the lumbar spine.

The lumbar artificial disc replacement comes in a variety of sizes, angles, and designs. The constrained-designed lumber artificial disc provides a fixed center of rotation that doesn't change. The unconstrained design allows the center of the implant to move forward and back slightly during lumbar motion.

Artificial cervical discs eliminate the potential complications and issues associated with the need for a bone graft and spinal instrumentation for spinal fusion and also allow for a quicker return to neck movement after surgery.

Further, the rising approvals for artificial discs will in turn propel the market in the forthcoming years. For instance, in April 2020, Centinel Spine, LLC, got FDA approval for its prodisc® L Total Disc Replacement device which is intended to replace damaged intervertebral discs in a patient's lower back (lumbar spine).

Thus, owing to the applications and advantages of artificial discs, the interplay of all the above factors is expected to drive the growth of the artificial discs category, thereby propelling the overall growth of the spinal non-fusion devices market during the forecast period from 2024 - 2030.

North America is expected to dominate the overall Spinal Non-Fusion Devices Market:

Among all the regions, North America is expected to hold the largest share of 59.57% in the global Spinal Non-Fusion Devices market in 2023. Some of the factors responsible for the growth of North America's Spinal Non-Fusion Devices market are the growing number of spinal cord injuries, and the rising number of accidents and falls in the region. Furthermore, the presence of key players and the rising product development activities such as launches and approvals about spinal non-fusion devices is also driving the growth of the spinal non-fusion devices market in North America.

For instance in the US, as per the Centers for Disease Control and Prevention (CDC) 2021, by 2040 there will be 78 million adults with OA. Also, according to statistics by the National Spinal Cord Injury Statistical Center (2019), the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,730 new SCI cases each year on average. Such a large increase in the number of OA and SCI cases can potentially increase the demand for spinal non-fusion devices in the upcoming years.

Also, advanced product launches with numerous products receiving regulatory approval are further expected to fuel the market for spinal non-fusion devices in the United States. For instance, in July 2021, Orthofix Inc., one of the prominent players in spinal injury devices received regulatory approval from the US Food and Drug Administration (FDA) for their Ascent POCT System, which is a spine stabilization system. Alos, in July 2022, Centinel Spine®, LLC, announced U.S. Food and Drug Administration (FDA) Pre-Market Application (PMA) Approval for 1-level indications for three additional cervical total disc replacement (TDR) devices: prodisc C Vivo, prodisc C Nova, and prodisc C SK, to provide the broadest offering of cervical TDR solutions in the world to address surgeon preference and individual patient anatomy.

Therefore, with the presence of a large patient population associated with spinal disorders, the increasing approvals for spinal non-fusion devices along with the presence of key players, among others is expected to bolster the growth of the spinal non-fusion devices market in the North American region during the forecast period from 2024-2030.

Spinal Non-Fusion Devices Market Key Players:

Some of the key market players operating in the Spinal Non-Fusion Devices market include Stryker, NuVasive Inc., Medtronic, ZimVie Inc., B. Braun SE, Surgalign Spine Technologies, Orthofix Medical Inc., Premia Spine, Globus Medical, Centinel Spine, LLC, Normed Medical, Neuro France Implants, Ackermann Medical GmbH & Co. KG, SpineVision, Aditus Medical, SIGNUS Medizintechnik GmbH, SpineSave AG, OrthoPediatrics Corp., Paonan Co., Ltd, Johnson & Johnson Services, Inc., and others.

Recent Developmental Activities in the Spinal Non-Fusion Devices Market:

• In June 2023, Premia Spine, received the Food and Drug Administration (FDA) approval of its Total Posterior Spine (TOPS) facet joint replacement system. The TOPS System previously earned the FDA's Breakthrough Designation status and has now successfully completed its Premarket Approval (PMA) application. The TOPS™ System replaces anatomical structures, such as the lamina or the facet joint that are removed from the vertebrae during the spinal decompression treatment to alleviate pain.
• In May 2021, Spinal Stabilization Technologies, Ltd., announced that the company earned the CE Mark and the FDA's "breakthrough designation" for its PerQdisc™ Nucleus Replacement System. The PerQdisc device replaces the nucleus pulposus of the intervertebral disc in the L1 - S1 spinal region in patients with single-level discogenic pain.
• In February 2019, Orthofix Medical Inc., got the US Food and Drug Administration (FDA) approval for the M6-C™ artificial cervical disc for patients suffering from cervical disc degeneration.

Key Takeaways from the Spinal Non-Fusion Devices Market Report Study

• Market size analysis for current Spinal Non-Fusion devices market size (2023), and market forecast for 5 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Spinal Non-Fusion devices market.
• Various opportunities available for the other competitor in the Spinal Non-Fusion devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Spinal Non-Fusion devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Spinal Non-Fusion devices market growth in the coming future?

Target Audience who can be benefited from this Spinal Non-Fusion Devices Market Report Study

• Spinal Non-Fusion devices products providers
• Research organizations and consulting companies
• Spinal Non-Fusion devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Spinal Non-Fusion devices
• Various end-users who want to know more about the Spinal Non-Fusion devices market and the latest technological developments in the Spinal Non-Fusion Devices market.

Frequently Asked Questions for the Spinal Non-Fusion Devices Market:

1. What are Spinal Non-Fusion devices?

Spinal non-fusion devices are medical devices that are employed in the correction of anatomical surgical defects of the spine using a non-fusion approach.

2. What is the market for global Spinal Non-Fusion devices?

The global Spinal Non-Fusion Devices market was valued at USD 2,757.17 million in 2023 and is likely to register a CAGR of 5.22% during the forecast period from 2024 to 2030 to reach USD 3,731.02 million by 2030.

3. What are the drivers for the global Spinal Non-Fusion Devices market?

The demand for spinal non-fusion devices is primarily being boosted owing to key factors such as the increasing prevalence of spinal disorders and deformities like spinal stenosis, degenerative disc disease (DDD), and others coupled with the rising burden of the geriatric population, and technological advancements in product portfolio coupled with increasing product development activities during the forecast period.

4. Who are the key players operating in the global Spinal Non-Fusion Devices market?

Some of the key market players operating in the Spinal Non-Fusion Devices market include Stryker, NuVasive Inc., Medtronic, ZimVie Inc., B. Braun SE, Surgalign Spine Technologies, Orthofix Medical Inc., Premia Spine, Globus Medical, Centinel Spine, LLC, Normed Medical, Neuro France Implants, Ackermann Medical GmbH & Co. KG, SpineVision, Aditus Medical, SIGNUS Medizintechnik GmbH, SpineSave AG, OrthoPediatrics Corp., Paonan Co., Ltd, Johnson & Johnson Services, Inc., and others.

5. Which region has the highest share in the Spinal Non-Fusion Devices market?

North America is expected to dominate the overall Spinal Non-Fusion Devices market during the forecast period from 2024-2030. The factors responsible for the growth of North America's Spinal Non-Fusion Devices market are the growing number of spinal cord injuries, and the rising number of accidents and falls among others in the region. Furthermore, the presence of key players and the rising product development activities such as launches and approvals pertaining to spinal non-fusion devices is also driving the growth of the spinal non-fusion devices market in North America.


This product will be delivered within 2 business days.